Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 USD | +0.58% | -.--% | +526.50% |
May. 24 | Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index | CI |
May. 23 | AbbVie Completes Acquisition of Landos Biopharma | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 11.41M |
---|---|---|---|---|---|
Net income 2022 | -39M | Net income 2023 | -21M | EV / Sales 2022 | - |
Net cash position 2022 | 44.4M | Net cash position 2023 | 37.5M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.51
x | P/E ratio 2023 |
-1.05
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 42.54% |
1 day | +0.58% | ||
1 month | +3.27% | ||
3 months | +267.47% | ||
6 months | +438.26% | ||
Current year | +526.50% |
1st Jan change | Capi. | |
---|---|---|
+526.50% | 71.68M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- LABP Stock